This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 2020 Jun 16;323(23):2365-2366.

doi: 10.1001/jama.2020.8863.

Emergency Use Authorization of Remdesivir: The Need for a Transparent Distribution Process

Michael G Ison¹, Cameron Wolfe², Helen W Boucher³

Affiliations

Affiliations

¹ Divisions of Infectious Diseases and Organ Transplantation, Northwestern University Feinberg School of Medicine, Chicago, Illinois.
² Division of Infectious Diseases, Duke University School of Medicine, Durham, North Carolina.
³ Division of Geographic Medicine and Infectious Diseases, Tufts Medical Center and Tufts University School of Medicine, Boston, Massachusetts.

PMID: 32407438
DOI: 10.1001/jama.2020.8863

Emergency Use Authorization of Remdesivir: The Need for a Transparent Distribution Process

Michael G Ison et al. JAMA. 2020.

. 2020 Jun 16;323(23):2365-2366.

doi: 10.1001/jama.2020.8863.

Authors

Michael G Ison¹, Cameron Wolfe², Helen W Boucher³

Affiliations

¹ Divisions of Infectious Diseases and Organ Transplantation, Northwestern University Feinberg School of Medicine, Chicago, Illinois.
² Division of Infectious Diseases, Duke University School of Medicine, Durham, North Carolina.
³ Division of Geographic Medicine and Infectious Diseases, Tufts Medical Center and Tufts University School of Medicine, Boston, Massachusetts.

PMID: 32407438
DOI: 10.1001/jama.2020.8863

No abstract available

PubMed Disclaimer

Similar articles

Missed Opportunities on Emergency Remdesivir Use.
Sarpatwari A, Kaltenboeck A, Kesselheim AS. Sarpatwari A, et al. JAMA. 2020 Jul 28;324(4):331-332. doi: 10.1001/jama.2020.11932. JAMA. 2020. PMID: 32579163 No abstract available.
A Proposed Lottery System to Allocate Scarce COVID-19 Medications: Promoting Fairness and Generating Knowledge.
White DB, Angus DC. White DB, et al. JAMA. 2020 Jul 28;324(4):329-330. doi: 10.1001/jama.2020.11464. JAMA. 2020. PMID: 32579158 No abstract available.
Allocating Remdesivir Under Scarcity: Social Justice or More Systemic Racism.
Weber E, Bliton MJ. Weber E, et al. Am J Bioeth. 2020 Sep;20(9):31-33. doi: 10.1080/15265161.2020.1795538. Am J Bioeth. 2020. PMID: 32840451 No abstract available.
Have we found the panacea to COVID-19 with remdesivir, an old but newly packaged drug?
Thalha AMM, Lee YY, Besari A, Omar SFS. Thalha AMM, et al. J R Coll Physicians Edinb. 2020 Jun;50(2):159-161. doi: 10.4997/JRCPE.2020.217. J R Coll Physicians Edinb. 2020. PMID: 32568289 Review. No abstract available.
A promising antiviral candidate drug for the COVID-19 pandemic: A mini-review of remdesivir.
Liang C, Tian L, Liu Y, Hui N, Qiao G, Li H, Shi Z, Tang Y, Zhang D, Xie X, Zhao X. Liang C, et al. Eur J Med Chem. 2020 Sep 1;201:112527. doi: 10.1016/j.ejmech.2020.112527. Epub 2020 Jun 6. Eur J Med Chem. 2020. PMID: 32563812 Free PMC article. Review.

See all similar articles

Cited by

Transparency, health equity, and strategies in state-based protocols for remdesivir allocation and use.
Kiptanui Z, Ghosh S, Ali S, Desai K, Harris I. Kiptanui Z, et al. PLoS One. 2021 Oct 18;16(10):e0257648. doi: 10.1371/journal.pone.0257648. eCollection 2021. PLoS One. 2021. PMID: 34662359 Free PMC article.
COVID-19 and care for patients with chronic kidney disease: Challenges and lessons.
Divyaveer S, Jha V. Divyaveer S, et al. FASEB Bioadv. 2021 Apr 29;3(8):569-576. doi: 10.1096/fba.2021-00002. eCollection 2021 Aug. FASEB Bioadv. 2021. PMID: 34230909 Free PMC article. Review.
A narrative review on adverse drug reactions of COVID-19 treatments on the kidney.
Jahanshahi F, Jazayeri SB, Eraghi MM, Reis LO, Hamidikia M, Amiri S, Aghamir SMK. Jahanshahi F, et al. Open Med (Wars). 2024 Mar 15;19(1):20230867. doi: 10.1515/med-2023-0867. eCollection 2024. Open Med (Wars). 2024. PMID: 38584847 Free PMC article. Review.
A Mini Review on Discovery and Synthesis of Remdesivir as an Effective and Promising Drug against COVID-19.
Zarenezhad E, Behrouz S, Farjam M, Rad MNS. Zarenezhad E, et al. Russ J Bioorg Chem. 2021;47(3):609-621. doi: 10.1134/S1068162021030183. Epub 2021 Jun 11. Russ J Bioorg Chem. 2021. PMID: 34149273 Free PMC article.
Metabolomic Approach to Identify the Potential Metabolites from Alpinia malaccensis for Treating SARS-CoV-2 Infection.
Jahan E, Mazumder T, Hasan T, Ahmed KS, Amanat M, Hossain H, Supty SJ, Liya IJ, Shuvo MSR, Daula AFMSU. Jahan E, et al. Biochem Genet. 2025 Aug;63(4):3287-3312. doi: 10.1007/s10528-024-10869-4. Epub 2024 Jul 2. Biochem Genet. 2025. PMID: 38955878

See all "Cited by" articles

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Silverchair Information Systems